NR and HTGS accession numbers for human carriers Oct. 10, 2000
(HTGS section is thoroughly searched, NR section is not)

Alphabetical list of acc nos. note: numbers in () and seq. numbers refer to 
Position in the alignment of 219 carriers.

AC000353.27  chromosome 11 = AP000944.3
AC004019.20  Chromosome 22 (95)
AC004958.1                 (105)
AC005618.1   chromosome 5  = AC008579.4 related to ORNT1
AC007506.1   chromosome 4  citrate related fragments
AC007643.3                 (134)
AC008053.5   chromosome 17 (103)
AC008104.3   chromosome 18 (184) UCP4
AC008488.6   chromosome 5  ANT3 pseudo 67% 
AC008579.4   chromosome 5  = AC005618.1  83% to AF177333.1
AC008595.5   chromosome 16 POOR MATCH PROBABLY NOT A CARRIER
AC009871.5                 87% to AC022960 = AC022598.3
AC009896.3   chromosome 3  (111)
AC010503.5   chromosome 19 (52)
AC010954.5                 (188) UCP1
AC011427.2   chr 5         (78) 
AC011457.1   chromosome 19 possible pseudogene to 111
AC011539.5   chromosome 19 (52A 2nd gene)
AC011933.4                 (101) = AC022211.3 chromosome 17
AC012213.3                 (123)
AC012525.6   chromosome 4  ANT3 pseudo 56% 
AC013627.3                 (55)
AC015501.4                 ANT1 LIKE FRAGMENTS 79%
AC015695.3   chromosome 11 64% to citrate (pseudogene)
AC016331.2   chromosome 19 (52) 
AC016331.2                 (52A 2nd gene chr 19) 
AC016486.4   chromosome 11 SAME AS AC055755.7 BUT DIFF CHROMOSOME
AC018410.3, AC022470.6 chromosome 6, AC024045.4 chromosome 11 67% to 125 
AC018739.4   chromosome 13 clone same as AL354798.6
AC018747.3                 = AP001522.2 
AC019121.3   chromosome 11 (194) UCP2
AC019151.2                 (106)
AC019152.5   chromosome 17 (106)
AC020568.4   chromosome 20 pseudogene similar to AL138752.5
AC020762.2   chromosome 16 N-terminal exon of ORNT1 like gene = AC073880.4
AC021286.3                 72% TO ANT1
AC021879.3   chromosome 18 = AC040947.2 chr 17 pseudogene = AL354765.2 chr 13
AC022211.3   chromosome 17 (101)
AC022220.7   chromosome X  ANT-LIKE FRAGMENTS
AC022285.10  chromosome 17 citrate carrier related C-term fragment
AC022293.14  chromosome 3  (137) PET8 HOMOL AC022894.2, AC069395.6 EST H08058
AC022470.6   chromosome 6  AC018410.3, AC024045.4 chromosome 11 67% to 125 
AC022597.2   chromosome 4  (132,136)
AC022598.3   chromosome 8  87% to AC022960 = AC009871.5
AC022860.3   chromosome 11 59% to citrate (pseudogene)
AC022894.2                 (137) PET8 HOMOL AC022293.14  chr 3, AC069395.6 EST H08058
AC022956.2   chromosome 1  UNKNOWN SEQ = AC022960.2 95% to AC022598.3
AC022960.2   chromosome 18 UNKNOWN SEQ = AC022956.2
AC023504.12  chromosome 3  ANT3 pseudo 78%
AC023824.2   chromosome 16 citrate carrier pseudogene
AC023868.2   chromosome 4  (1 ANT1)
AC024029.3   chromosome 11 UCP2
AC024045.4   chromosome 11 AC022470.6 chromosome 6  AC018410.3, 67% to 125 
AC024676.2   chromosome 4  59% to Grave's antigen = AC074273.4
AC025032.10  chromosome 3  93% TO SEQ 44 POSSIBLE PSEUDO
AC025170.4   chromosome 5  99% to AC008488.6 one stop more may be same pseudogene
AC025326.3   chromosome 2  (106)
AC025490.2                 (188) UCP1
AC025517.2   chromosome 4  89% TO SEQ 198 pseudogene
AC026078.3   chromosome 11 (113) 3 diffs
AC026309.15  chromosome 3  (44)
AC026546.3   chromosome 1  similar to seq 103 = AC058783.10
AC027433.2   chromosome 18 phosphate carrier pseudogene
AC027723.2   chromosome 10 probable ORNT1 pseudogene
AC027760.1   Chromosome 22 (95) 
AC032038.2   chromosome 17 (178) OXOGLUTARATE
AC036184.3   chromosome 2  FRAGMENT 72% TO ANT2
AC037456.6   chromosome 10 (57) GRAVE'S DISEASE ANTIGEN 
AC040947.2   chromosome 17 pseudogene = AL354765.2 chromosome 13
AC051642.2   chromosome 8  (132, 136) 1 DIFF
AC055755.7   chromosome 3  PSEUDO TO SEQ 151 CITRATE
AC055828.2                 58% to citrate (pseudogene)
AC058783.10  chromosome 1  = AC026546.3
AC058813.2   chromosome 17 (101)
AC067895.2   chromosome 6 78% to seq 95
AC068039.3   chromosome 2  (89) SLC25A12
AC068429.2   chromosome 3  (111)
AC068848.2   very similar to AL138752.5 with internal frame shift pseudogene
AC069303.2   chromosome 2  ANT3 pseudo 88%
AC069395.6                 (137) PET8 HOMOL AC022293.14  chr 3, AC022894.2 EST H08058
AC073188.3   chromosome 7  54% to citrate (pseudogene)
AC073194.4   chromosome 11 (113)
AC073199.3   chromosome 6  = AL354943.8 chromosome 6 ANT PSEUDOGENE 
AC073269.4   chromosome 7  88% to ANT3 no stops for pseudo new ANT?
AC073598.1   chromosome 10 93% TO AC022960.2
AC073645.2   chromosome 11 UCP3
AC073880.4                 9 diffs to ORNT1 partial seq 
AC074078.1                 = AL391221.6 chromosome 6 PSEUDOGENE 84% TO 74 CARNITINE
AC074273.4   chromosome 4  59% to grave's antigen = AC024676.2 chromosome 4
AF050113.1                 (193) UCP3
AF112968.1                 ORNT1 ornithine = = AF177333.1
AF118838                   citrin (SLC25A13)
AF123303                   (55) peroxisomal calcium dependent transporter
AF125531.1                 (105)
AF177333.1   unknown mRNA  = NM_000387.2 ORNT1 ornithine 83% to AC008579.4
AF182404.1                 (101)
AF216674.2   chromosome 8  (132, 136) 3 DIFFS
AF223466.1                 (132,136)
AF254982.1   chromosome 21 clone probable ORNT1 pseudogene
AK000766.1                 (91) very similar to citrin
AK001480.1                 (111)
AK023106.1                 (94)
AK025227.1                 (91)
AK025779.1                 (91)
AL034343.17                = AL391221.6 84% TO CARNITINE CARRIER
AL035423.4                 (198) BMCP1 brain mito carrier protein 1
AL046268.1                 (123)
AL135838.3   chromosome 14 = AL157871.2
AL138752.5   chr 9p12          EST FOR N-TERM = AA149221
AL139386.7   chromosome 13 ORNT1 pseudogene
AL157871.2   chromosome 14 UNKNOWN SEQUENCE = AL135838.3
AL161614.5   chromosome 13 ORNT1
AL161783.5   chromosome 9  ANT3 pseudo 95% to AL353573.10 
AL353573.10  chromosome 9  ANT3 pseudo 84%
AL353716.9   chromosome 6  ANT3-LIKE N-TERM FRAG
AL353719.5   chromosome 10 (134)
AL354765.2   chromosome 13 = AC040947.2 chromosome 17 pseudogene
AL354798.6   chromosome 13 probable ORNT1 pseudogene = AC018739.4
AL354854.5   chromosome 9  ANT2 pseudo 85%
AL354943.8   chromosome 6  ANT PSEUDOGENE
AL355513.4   chromosome 6  84% TO CARNITINE CARRIER SEQ 74 PSEUDO = AL391221.6
AL356110.1   chromosome 1  (55) peroxisomal calcium dependent transporter
AL356259.3   chromosome 13 partial seq like ORNT1
AL356977.7   chromosome 1  phosphate carrier related 68% pseudogene = AL365445.6
AL359258.4   chromosome 1  (52B)
AL359537.4   chromosome X  citrate carrier
AL360177.1   chromosome 10 (57) GRAVES
AL360268.4   chromosome 9  (50,53)
AL365445.6   chromosome 1  phosphate carrier related 68% pseudogene = AL356977.7
AL390036.6   chromosome 1  (55) peroxisomal calcium dependent transporter
AL390038.5   chromosome 1  56% to seq 50/53 one short fragment
AL390963.4   chromosome 1  59% to 106
AL390965.10  chromosome 13 ANT3 pseudo 63%
AL391096.8   chromosome X  Citrate carrier
AL391221.6   chromosome 6  84% TO CARNITINE CARRIER SEQ 74 PSEUDO = AL355513.4
AL391500.2   chromosome 6  89% to AL138752.5
AL392084.3   chromosome 9  ANT PSEUDO
AP000645.2   chromosome 11 = AP000767.3 80% to CITRATE (pseudogene)
AP000767.3   chromosome 11 = AP000645.2 80% to CITRATE (pseudogene)
AP000944.3   chromosome 11 57% TO AL157871.2 = AC000353.27 Chromosome 11q13
AP001522.2   chromosome 18 ANT LIKE FRAGMENTS
AX004413.1                 (91)
L77567.1                   (151) citrate transport protein (CTP)
NM_000387.2                (74) HUMAN CARNITINE
NM_003705                  (89) solute carrier family 25 (mito carrier, Aralar
NM_012140                  DIC
NM_014251.1                (91) solute carrier fam 25, member 13 (citrin) (SLC25A13)
NM_014252.1                = AF177333.1 ORNT1 ornithine
NM_018155.1                (111)  
U25147                     (151) citrate
U28480                     (188) UCP1
U82819                     (194) UCP2
Y10319.1                   (74) HUMAN CARNITINE
Y17571.1                   (91) ARALAR2
Z28872                     (74) HUMAN CARNITINE
Z58487.1 genomic frag.     (78)